Article
|
|
|
Services
|
|
|
Google Scholar
|
|
|
PubMed
|
|
Articles in PubMed by Author:
|
|
PubMed
|  |
|
|
REPLY
Outpatient Management of HIV-Related Pneumonia
Henry Masur, MD, and
James H. Shelhamer, MD
1 December 1996 | Volume 125 Issue 11 | Pages 938-939
IN RESPONSE:
Dr. Becker raises two issues that were not explicitly addressed in our editorial. First, if the result of an induced-sputum examination is negative for P. carinii, what diagnosis is likely? Second, if the result of an induced-sputum examination is negative for P. carinii, what diagnostic procedures should be used?
Regarding the first issue, we believe that at many institutions, induced sputum examination has a high sensitivity for P. carinii pneumonia in patients who are and are not receiving prophylaxis for P. carinii pneumonia (sensitivity, >60% and >90%, respectively) [1]. However, we do not agree that a negative result of induced-sputum examination in this setting makes other pulmonary diagnoses substantially more likely than a diagnosis of P. carinii pneumonia. Huang and colleagues [2] reported that in patients who have HIV infection, low CD4 counts, a clinical picture typical of P. carinii pneumonia, and a negative result of an induced-sputum examination, the most likely diagnosis is P. carinii pneumonia. In that study [2] (which was done at an institution with considerable experience assessing induced-sputum samples), 192 of 602 (31%) patients with negative results of induced-sputum examinations were found to have P. carinii pneumonia at bronchoscopy. This diagnosis was substantially more common than that of M. tuberculosis infection (<5%) or fungal infection (<5%).
The second issue raised by Dr. Becker is what procedures should be done to establish the diagnosis of pulmonary disease when the result of an induced-sputum examination is negative. Depending on the reliability of the laboratory and the quality of the specimen, a second induced-sputum sample might be useful. Most clinicians would do bronchoalveolar lavage after the initial induced-sputum analysis and consider the merit of transbronchial biopsy during the initial bronchoscopy. Transbronchial lung biopsy is associated with a slightly increased sensitivity of the bronchoscopic procedure for P. carinii pneumonia and may either enhance the sensitivity or be required to establish a diagnosis of tuberculosis, cytomegalovirus pneumonia, fungal pneumonia, or such noninfectious processes as lymphocytic interstitial pneumonitis or some pulmonary cancers [3, 4]. It is reasonable, as Dr. Becker has done, to advocate a diagnostic procedure that includes bronchoscopy, bronchoalveolar lavage, and transbronchial lung biopsy during the initial bronchoscopic procedure for patients who present with a clinical picture that suggests P. carinii pneumonia and a negative result of induced-sputum examination. However, our general practice is to do only bronchoscopy and bronchoalveolar lavage. If those procedures fail to indicate a diagnosis, we repeat them, adding the transbronchial biopsy.
In geographic areas where tuberculosis, histoplasmosis, or coccidiomycosis is especially common or in health care settings where induced-sputum evaluation is insensitive, a different algorithm encouraging bronchoscopy with or without transbronchial biopsy may be indicated.
|
Author and Article Information
|
|---|
National Institutes of Health, Bethesda, MD 20892.
1. Gill V, Quinn T, Crawford S, Kovacs J, Masur H, Ognibene F, et al. Diagnosis of pulmonary opportunistic infections. Ann Intern Med. 1996; 124:585-99.
2. Huang L, Hecht F, Stansell J, Montanti R, Hadley W, Hopewell P. Suspected Pneumocystis carinii pneumonia with a negative induced sputum examination. Am J Respir Crit Care Med. 1995; 151:1866-71.
3. Barnes P, Steele M, Young S, Vachon L. Tuberculosis in patients with human immunodeficiency virus infection. Chest. 1992; 102:428-32.
4. Kennedy D, Lewis W, Barnes P. Yield of bronchoscopy for the diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Chest. 1992; 102:1040-4.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Article
|
|
|
Services
|
|
|
Google Scholar
|
|
|
PubMed
|
|
Articles in PubMed by Author:
|
|
PubMed
|  |
|
|